Science Corporation, a competitor of Elon Musk's Neuralink, offers a brain-computer interface retinal implant designed to restore vision in patients with macular degeneration.

The Massachusetts-based company will use the funds to advance its Spectris neurotechnology platform that uses visual and auditory stimulation to treat Alzheimer's disease.

The company will use the funds to expand its platform that connects caregivers, care teams and residents in senior living and long-term care facilities.

As CMS removes procedures from its Inpatient-Only (IPO) list, Allison Oakes, Trilliant's chief research officer, recommends that hospitals establish a clear outpatient strategy to avoid losing the income these procedures bring.

The company offers agentic AI agents designed to assist healthcare teams with tasks such as patient scheduling, intake, insurance verification and patient outreach.

The New York-based company will use the funds to expand its in-person and online therapy platform.